| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelic...
																	Numinus Wellness Inc.
																	After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychoth...
																	The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports fo...
																	June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF).
																	The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.
																	Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with ...
																	In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to ta...